Veracyte, Inc. Stock Performance

Open $39.53	Prev. Close $38.61	Circuit Range N/A
Day Range $39.38 - $40.70	Year Range $29.45 - $60.77	Volume 78,548
Average Traded $40.10

Veracyte, Inc. Share Price Today

As of 18 September 2026, Veracyte, Inc.'s share price is $40.56. The stock opened at $39.53, compared to its previous close of $38.61. During today's trading session, Veracyte, Inc.'s share price traded between $39.38 and $40.70, with an average price of $40.04. Over the past 52 weeks, the stock has recorded a high of $60.77 and a low of $29.45. In terms of performance, Veracyte, Inc.'s share price has risen by 26.01% over the last six months and is up 18.22% on a year-on-year basis.

Veracyte, Inc. Share Price Chart

$39.38$40.70

Veracyte, Inc. Stock Fundamentals & Key Indicators

Market Cap $3.19B	PE Ratio (TTM) 48.29	Dividend Yield N/A
EPS (TTM) $0.84	Revenue (TTM) $517.14M	Return On Equity (TTM) 5.07%
Profit Margin 12.83%	Debt to Equity 0.05	Quarterly Earnings Growth YoY 26.28%

Veracyte, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	-$73.31M	-$66.99M	-$76.60M	-$95.04M	-$68.34M
Net Profit	-$1.86M	$5.73M	$15.15M	$7.05M	-$980000.00	$19.14M
Net Profit Margin	N/A	-7.82%	-22.62%	-9.20%	1.03%	-28.00%
Income Change	N/A	407.62%	164.30%	-53.50%	-113.91%	2052.76%

Veracyte, Inc. Annual Profit & Loss

All figures in USD

Particulars	2021	2022	2023	2024	2025
Revenue	-$301.42M	-$337.62M	-$446.85M	-$282.00M	-$304.75M
Net Profit	-$75.56M	-$36.56M	-$74.40M	$24.14M	$66.35M
Net Profit Margin	25.07%	10.83%	16.65%	-8.56%	-21.77%
Income Change	N/A	51.62%	-103.51%	132.44%	174.89%

About Veracyte, Inc.

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Veracyte, Inc. Historical Returns

Month	Open	Close	Change %
Sep 2026	$42.85	$40.55	-10.45%
Aug 2026	$46.36	$45.28	-1.84%
Jul 2026	$59.48	$46.13	-21.42%
Jun 2026	$46.25	$58.70	+26.63%
May 2026	$32.95	$46.36	+40.80%
Apr 2026	$32.30	$32.92	+2.29%
Mar 2026	$35.88	$32.19	-11.94%
Feb 2026	$38.17	$36.55	-3.93%
Jan 2026	$42.36	$38.05	-9.65%
Dec 2025	$46.84	$42.12	-11.04%
Nov 2025	$35.80	$47.34	+30.38%
Oct 2025	$34.20	$36.31	+5.83%

VCYT Share Price FAQs

What is Veracyte, Inc. share price today?

Veracyte, Inc. share price today is $40.56 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Veracyte, Inc. stock?

The 52 week high of Veracyte, Inc. stock is $60.77, while the 52 week low is $29.45 as of 18 Sep '26.

What is VCYT's market capitalisation today?

VCYT market capitalisation is $3.19B as of September 18, 2026, at 2:49 pm IST.

What is VCYT's net income for the last quarter?

VCYT's net income for the last quarter is 0.02B USD.

What is the 5 year returns of VCYT?

The 5 year returns of VCYT is -12.68% as on 18 Sep '26.

What is the high & low stock price of VCYT today?

VCYT stock price hit a high of $40.70 and low of $39.38 as of 18 Sep '26.

Can I buy VCYT shares in India?

Yes. You can buy VCYT in India by opening an international trading account.